Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.25.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 20,116 $ 16,856
Restricted cash 953 958
Other current assets 2,464 2,706
Total current assets 23,533 20,520
Non-current assets    
Non-current restricted cash 161 161
Operating lease right-of-use assets 5,209 5,457
Property and equipment, net 4,701 5,045
In-process Research and development asset 12,050 12,050
Total non-current assets 22,121 22,713
Total Assets 45,654 43,233
Current liabilities    
Trade accounts payable 1,670 1,882
Current portion of lease liabilities 1,141 1,130
Other accounts payable 4,210 5,255
Total current liabilities 7,021 8,267
Non-current liabilities    
Operating lease liabilities, net of current portion 8,151 8,454
Other liabilities 79 77
Warrants 5,904 2,287
Total non-current liabilities 14,134 10,818
Commitments and Contingencies (Note 6)
Stockholders’ equity    
Preferred Stock, $0.0001 par value; Authorized – 1,000,000 shares as of March 31, 2025 and December 31, 2024. Issued and outstanding- 147,735 as of March 31, 2025 and December 31, 2024. 18,645 18,645
Common Stock, $0.0001 par value; Authorized – 750,000,000 shares as of March 31, 2025 and December 31, 2024. Issued and outstanding- 24,966,053 shares as of March 31, 2025 and 18,176,661 shares as of December 31, 2024. 7 6
Additional paid in capital 194,203 186,194
Accumulated deficit (188,356) (180,697)
Total stockholders’ equity 24,499 24,148
Total liabilities and stockholders’ equity $ 45,654 $ 43,233